Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01479231

Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis

Predictors of PPI Response in Eosinophilic Esophagitis

Status
Withdrawn
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The investigators will determine the prevalence of gastroesophageal reflux disease (GERD) in Eosinophilic Esophagitis (EoE) and importantly determine the predictors of response to Proton Pump Inhibitor (PPI) therapy in EoE. Moreover, the investigators will determine the effect of GERD on the location of esophageal eosinophilia.

Conditions

Interventions

TypeNameDescription
DRUGdexlansoprazoleDexlansoprazole 60 mg daily for 6 weeks

Timeline

Start date
2012-03-01
Primary completion
2012-03-01
Completion
2012-03-01
First posted
2011-11-24
Last updated
2012-04-19

Source: ClinicalTrials.gov record NCT01479231. Inclusion in this directory is not an endorsement.